Seroepidemiological studies indicate frequent and repeated exposure to Campylobacter spp. during childhood

Epidemiology and Infection

Volumn 139, Issue 9, 2011, Pages 1361-1368

  Ang, C W ^a   Teunis, P F M ^b,c   Herbrink, P ^d   Keijser, J ^d   Van Duynhoven, Y H T P ^b   Visser, C E ^e   Van Pelt, W ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c EMORY UNIVERSITY   (United States)

^d REINIER DE GRAAF HOSPITAL   (Netherlands)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Campylobacter; foodborne infection; gastrointestinal infections; mathematical modelling; serology

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; CAMPYLOBACTER; CAMPYLOBACTER COLI; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER FETUS; CAMPYLOBACTER HYOINTESTINALIS; CAMPYLOBACTER JEJUNI; CAMPYLOBACTER LARI; CAMPYLOBACTER UPSALIENSIS; CAMPYLOBACTERIOSIS; CHILD; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER PYLORI; HUMAN; IMMUNOREACTIVITY; INFANT; LEGIONELLA PNEUMOPHILA; MALE; NETHERLANDS; PRESCHOOL CHILD; SCHOOL CHILD; SEROEPIDEMIOLOGY; SEROPREVALENCE; SYMPTOMATOLOGY; URBANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; CAMPYLOBACTER INFECTIONS; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROENTERITIS; HUMANS; IMMUNOGLOBULIN G; INFANT; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES;

EID: 80053098672     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268810002359     Document Type: Article

References (24)

1. Havelaar AH, et al. Health loss by microbial agents in food. In: Future Explorations of Public Health, National Compass of Public Health. Bilthoven: RIVM, 2008
2. Havelaar AH, et al. Health burden in The Netherlands due to infection with thermophilic Campylobacter spp. Epidemiology and Infection 2000; 125: 505-522 (Pubitemid 32156840)
3. De Wit MA, et al. Sensor, a population-based cohort study on gastroenteritis in the Netherlands: incidence and etiology. American Journal of Epidemiology 2001; 154: 666-674 (Pubitemid 32888785)
4. Wheeler JG, et al. Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. The Infectious Intestinal Disease Study Executive. British Medical Journal 1999; 318: 1046-1050 (Pubitemid 29191897)
5. Van Pelt W, et al. Laboratory surveillance of bacterial gastroenteric pathogens in The Netherlands, 1991- 2001 Epidemiology and Infection 2003; 130: 431-441 (Pubitemid 36722781)
6. Samuel MC, et al. Epidemiology of sporadic Campylobacter infection in the United States and declining trend in incidence, FoodNet 1996-1999 Clinical Infectious Diseases 2004; 38 Suppl 3: S165-174 (Pubitemid 38553321)
7. Rajan DP, Mathan VI. Prevalence of Campylobacter fetus subsp. jejuni in healthy populations in southern India. Journal of Clinical Microbiology 1982; 15: 749-751 (Pubitemid 12109353)
8. Glass RI, et al. Epidemiologic and clinical features of endemic Campylobacter jejuni infection in Bangladesh. Journal of Infectious Diseases 1983; 148: 292-296 (Pubitemid 13002464)
9. Coker AO, et al. Human campylobacteriosis in developing countries. Emerging Infectious Diseases 2002; 8: 237-244
10. Belongia EA, et al. Diarrhea incidence and farmrelated risk factors for Escherichia coli O157:H7 and Campylobacter jejuni antibodies among rural children. Journal of Infectious Diseases 2003; 187: 1460-1468 (Pubitemid 36549692)
11. Linneberg A, et al. IgG antibodies against microorganisms and atopic disease in Danish adults : the Copenhagen Allergy Study. Journal of Allergy and Clinical Immunology 2003; 111: 847-853 (Pubitemid 36470259)
12. De Melker HE, Conyn-van Spaendonck MA. Immunosurveillance and the evaluation of national immunization programmes: a population-based approach. Epidemiology and Infection 1998; 121: 637-643 (Pubitemid 29023043)
13. Allos BM. Campylobacter jejuni infections : update on emerging issues and trends. Clinical Infectious Diseases 2001; 32: 1201-1206 (Pubitemid 32381123)
14. Ang CW, et al. Validation of an ELISA for the diagnosis of recent Campylobacter infections in Guillain-Barré and reactive arthritis patients. Clinical Microbiology and Infection 2007; 13: 915-922 (Pubitemid 47244142)
15. Ramsay JO. Monotone regression splines in action. Statistical Science 1988; 3: 425-441
16. Harrell Jr. FE. Regression Modeling Strategies. New York: Springer-Verlag, 2001
17. Gilks WR, et al. Markov Chain Monte Carlo in Practice. London: Chapman and Hall, 1996
18. Simonsen J, et al. Seroepidemiology as a tool to study the incidence of Salmonella infections in humans. Epidemiology and Infection 2008; 136: 895-902 (Pubitemid 351712524)
19. Blaser MJ, Duncan DJ. Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay. Infection and Immunity 1984; 44: 292-298 (Pubitemid 14139793)
20. Martin PM, et al. Immune response to Campylobacter jejuni and Campylobacter coli in a cohort of children from birth to 2 years of age. Infection and Immunity 1989; 57: 2542-2546 (Pubitemid 19183871)
21. Figueroa G, et al. Prospective study of Campylobacter jejuni infection in Chilean infants evaluated by culture and serology. Journal of Clinical Microbiology 1989; 27: 1040-1044 (Pubitemid 19115686)
22. Blaser MJ, et al. Campylobacter jejuni-specific serum antibodies are elevated in healthy Bangladeshi children. Journal of Clinical Microbiology 1985; 21: 164-167 (Pubitemid 15161106)
23. Baqar S, et al. Campylobacter jejuni enteritis. Clinical Infectious Diseases 2001; 33: 901-905 (Pubitemid 32831849)
24. Rollwagen FM, et al. Killed Campylobacter elicits immune response and protection when administered with an oral adjuvant. Vaccine 1993; 11: 1316-1320 (Pubitemid 23319659)